Enzon Pharmaceuticals (OTCMKTS:ENZN) Share Price Passes Above 200-Day Moving Average – Time to Sell?

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.13 and traded as high as $0.20. Enzon Pharmaceuticals shares last traded at $0.19, with a volume of 683,174 shares.

Enzon Pharmaceuticals Price Performance

The stock has a fifty day moving average of $0.10 and a 200 day moving average of $0.13. The stock has a market cap of $13.95 million, a price-to-earnings ratio of 18.81 and a beta of 0.49.

Enzon Pharmaceuticals Company Profile

(Get Free Report)

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.

Recommended Stories

• Five stocks we like better than Enzon Pharmaceuticals
• 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
• XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
• Best ESG Stocks: 11 Best Stocks for ESG Investing
• CarMax Gets in Gear: Is Now the Time to Buy?
• What is the S&P/TSX Index?
• Qubit Combat: 2 Stocks Battle for Quantum Supremacy